Champions Oncology is engaged in drug discovery and development through research strategies and pharmacology, biomarker and data platforms. Co.'s research services utilize its research center to assist pharmaceutical and biotechnology companies with their drug development process. Co.'s Software as a service business is centered around its proprietary software platform and data tool, Lumin Bioinformatics, which contains information derived from its research services and clinical studies. Co.'s drug discovery and development business utilizes the computational and experimental capabilities within its platforms. We show 36 historical shares outstanding datapoints in our CSBR shares outstanding history coverage, used to compute CSBR market cap on those dates.
Understanding the changing numbers of shares outstanding, the changing
share price, and the resulting changing CSBR market cap history over the course of time is important for investors
interested in comparing CSBR's market cap history versus its peers.
Many "beginner" or "novice" investors will look at one stock trading at a price of $10 per share and another trading at
a price of $20 per share and think the latter company is worth twice as much. Of course, that is a completely meaningless comparison without also knowing how many shares outstanding there are for each of the two companies,
and then calculating their respective market caps. Comparing the share price of CSBR versus a peer is one thing; comparing
CSBR market cap versus a peer is a completely different story.
Furthermore, via fluctuation both in per-share price and in the number of shares outstanding (via issuance of new shares over time, the repurchase of existing shares),
the market cap for a company like CSBR can fluctuate over the course of history.
With this page we aim to empower investors researching CSBR by allowing them to research the CSBR market cap history. |
Free CSBR Email Alerts:
Video: The Importance of Market Cap
